Abstract:Mitochondrial network is constantly in a dynamic and regulated balance of fusion and fission processes, which is known as mitochondrial dynamics. Mitochondria make physical contacts with almost every other membrane in the cell thus impacting cellular functions. Mutations in mitochondrial dynamics genes are known to cause neurogenetic diseases. To better understand the consequences on the cellular phenotype and pathophysiology of neurogenetic diseases associated with defective mitochondrial dynamics, we have compared the fibroblasts phenotypes of (i) patients carrying pathogenic variants in genes involved in mitochondrial dynamics such as DRP1 (also known as DNM1L ), GDAP1 , OPA1 , and MFN2 , and (ii) patients carrying mutated genes that their dysfunction affects mitochondria or induces a mitochondrial phenotype, but that are not directly involved in mitochondrial dynamic network, such as FXN (encoding frataxin, located in the mitochondrial matrix), MED13 (hyperfission phenotype), and CHKB (enlarged mitochondria phenotype). We identified mitochondrial network alterations in all patients’ fibroblasts except for CHKB Q198*/Q198* . Functionally, all fibroblasts showed mitochondrial oxidative stress, without membrane potential abnormalities. The lysosomal area and distribution were abnormal in GDAP1 W67L/W67L , DRP1 K75E/+ , OPA1 F570L/+ , and FXN R165C/GAA fibroblasts. These lysosomal alterations correlated with mitochondria-lysosome membrane contact sites (MCSs) defects in GDAP1 W67L/W67L exclusively. The study of mitochondrial contacts in all samples further revealed a significant decrease in MFN2 R104W/+ fibroblasts. GDAP1 and MFN2 are outer mitochondrial membrane (OMM) proteins and both are related to Charcot-Marie Tooth neuropathy. Here we identified their constitutive interaction as well as MFN2 interaction with LAMP-1. Therefore MFN2 is a new mitochondria-lysosome MCSs protein. Interestingly, GDAP1 W67L/W67L and MFN2 R104W/+ fibroblasts carry pathogenic changes that occur in their catalytic domains thus suggesting a functional role of GDAP1 and MFN2 in mitochondria–lysosome MCSs. Finally, we observed starvation-induced autophagy alterations in DRP1 K75E/+ , GDAP1 W67L/W67L , OPA1 F570L/+ , MFN2 R104W/+ , and CHKB Q198*/Q198* fibroblasts. These genes are related to mitochondrial membrane structure or lipid composition, which would associate the OMM with starvation-induced autophagy. In conclusion, the study of mitochondrial dynamics and mitochondria-lysosome axis in a group of patients with different neurogenetic diseases has deciphered common and unique cellular phenotypes of degrading and non-degrading pathways that shed light on pathophysiological events, new biomarkers and pharmacological targets for these disorders.

Mitochondrial Defects in Fibroblasts of Pathogenic MAPT Patients

MAPT Mutations V337M and N297K Alter Organelle Trafficking in Frontotemporal Dementia Patient-Specific Motor Neurons

Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy

Disease-associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria

Mitochondrial bioenergetics stimulates autophagy for pathological MAPT/Tau clearance in tauopathy neurons

Cell autonomous microglia defects in a stem cell model of frontotemporal dementia

The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy

The disease-causing tau V337M mutation induces tau hypophosphorylation and perturbs axon morphology pathways

Mitochondrial and Clearance Impairment in p.D620N VPS35 Patient-Derived Neurons

Mitochondrial Dynamics and Mitochondria-Lysosome Contacts in Neurogenetic Diseases

Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy

Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation

Broad activation of the PRKN pathway triggers synaptic failure by disrupting synaptic mitochondrial supply in early tauopathy

Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca2+ and synaptic defects

Abnormal Mitochondria in a Non-human Primate Model of MPTP-induced Parkinson's Disease: Drp1 and CDK5/p25 Signaling

iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to caspase-mediated cleavage of tau and apoptotic cell death

Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps

MMP-9 and MMP-2 Contribute to Neuronal Cell Death in Ipsc Models of Frontotemporal Dementia with MAPT Mutations.

Mitochondria Dysfunction in Charcot Marie Tooth 2B Peripheral Sensory Neuropathy

Chronic Progressive External Ophthalmoplegia Coexistent with Motor Neuron Disease in A Patient with A Novel Large-Scale Mitochondrial Dna Deletion

Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates Inflammation